<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7F71BABD-BB5E-465A-A468-AD99CA3C8DA6"><gtr:id>7F71BABD-BB5E-465A-A468-AD99CA3C8DA6</gtr:id><gtr:name>Bandim Health Project (BHP)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/6083E7FB-0220-4F5F-97B0-7F6113B49A0C"><gtr:id>6083E7FB-0220-4F5F-97B0-7F6113B49A0C</gtr:id><gtr:name>MRC Unit, The Gambia</gtr:name><gtr:address><gtr:line1>MRC Laboratories, The Gambia</gtr:line1><gtr:line2>Atlantic Road PO Box 273</gtr:line2><gtr:line4>Fajara</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Gambia</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6083E7FB-0220-4F5F-97B0-7F6113B49A0C"><gtr:id>6083E7FB-0220-4F5F-97B0-7F6113B49A0C</gtr:id><gtr:name>MRC Unit, The Gambia</gtr:name><gtr:address><gtr:line1>MRC Laboratories, The Gambia</gtr:line1><gtr:line2>Atlantic Road PO Box 273</gtr:line2><gtr:line4>Fajara</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Gambia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7F71BABD-BB5E-465A-A468-AD99CA3C8DA6"><gtr:id>7F71BABD-BB5E-465A-A468-AD99CA3C8DA6</gtr:id><gtr:name>Bandim Health Project (BHP)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/F791A50A-5471-4816-A7D5-93C0288A822B"><gtr:id>F791A50A-5471-4816-A7D5-93C0288A822B</gtr:id><gtr:firstName>C</gtr:firstName><gtr:surname>van Tienen</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U190081997"><gtr:id>9E8207E0-21B3-48EA-8B33-B08F31FF67F0</gtr:id><gtr:title>CAIO HIV Sero-Survey, 2006</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U190081997</gtr:grantReference><gtr:abstractText>The Viral Diseases Programme has been conducting studies on pathogenesis and immunology of HIV-2 since 1995 and has recently started studies on HTLV-1 pathogenesis We are planning a number of studies to take advantage of the extraordinary resource of an HIV-2-infected community cohort with more than 15 years of follow-up in order to advance our understanding of HIV-2 pathogenesis and protective immunity. Recent studies in the Caio have indicated that there is a significant increase in mortality in HTLV-1-infected people, similar to that seen overall in the HIV-2. The reasons for the increased mortality rate associated with HTLV-1 infection are not clear. Studies have been proposed to investigate the potential for HTLV-1 to reduce the immune response to other pathogens and vaccines. We aim to link the serosurvey with the proposed rollout of ART in Guinea-Bissau (generic drugs provided by the Brazilian government) so that the participants will be able to link knowledge of their HIV status with access to ART where appropriate. We are coordinating with the Guinean National AIDS Control Programme to provide HIV testing and therapy if indicated.</gtr:abstractText><gtr:technicalSummary>Caio region has a population of about 11,000, with approximately 4000 adults, in the north-west of Guinea-Bissau in the Cacheu region. Serosurveys among adults in the community was performed in 1989 and 1996-1998. These surveys indicate that HIV-2 prevalence remains stable at around 7.8%, whilst HIV-1 prevalence is increasing (2. 7%). We have been conducting studies on HIV-2 in this community since 1995 and have recently started studies on HTLV-1. We will identify all newly infected HIV and HTLV-1 infected persons in order to undertake proposed studies for advancing our understanding of HIV-2 pathogenesis and protective immunity, and for understanding the interaction between HTLV-1 and other infections. We aim to link the serosurvey with the proposed roll-out of ART in Guinea-Bissau so that the participants will be able to link their HIV status with access to ART. After the consent, pre-test counselling and a short interview, 2.5 ml venous blood will be collected from all men and women ?15 years of age by trained field workers for HIV and HTLV, haemoglobin, malaria parasites, and syphilis screening. Subjects with anaemia, malaria, or syphilis will be offered treatment. They will be requested to collect results of HIV and HTLV screening and to attend post-test counselling at the MRC station after a month.</gtr:technicalSummary><gtr:fund><gtr:end>2008-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-01-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>785469</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Infection and Immunity</gtr:department><gtr:description>phylogenetic analyses of HIV sequences</gtr:description><gtr:id>90483AF6-E20B-4BD8-A864-4146AFA86E8B</gtr:id><gtr:impact>at least 2 papers that are in preparation and almost ready for submission</gtr:impact><gtr:outcomeId>sFQTB23oggA-1</gtr:outcomeId><gtr:partnerContribution>-support and do phylogenetic analyses to gain a further insight into hiv-2 and hiv-1 pathogenesis and spread</gtr:partnerContribution><gtr:piContribution>We have initiated this collaboration in order to do more elaborate analyses of the HIV-1 and hiV-2 sequences derived from Caio</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Bandim Health Project (BHP)</gtr:collaboratingOrganisation><gtr:country>Denmark, Kingdom of</gtr:country><gtr:description>longstanding collaboration with Bandim Health Project, Bissau</gtr:description><gtr:id>515AB140-4D2D-431B-992E-78AEF6A7F8AA</gtr:id><gtr:impact>19841588</gtr:impact><gtr:outcomeId>015932FE08D-1</gtr:outcomeId><gtr:partnerContribution>there is a continued managerial and intellectual collaboration between the Bandim Health Project and the MRC-exchange of intellectual ideas
-inspiration
-practical help with samples</gtr:partnerContribution><gtr:piContribution>frequent updates on our study and visits to the Bandim Health Project, collaborations on setting up anti-retroviral treatment program in Caio</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Bandim Health Project (BHP)</gtr:collaboratingOrganisation><gtr:country>Denmark, Kingdom of</gtr:country><gtr:description>longstanding collaboration with Bandim Health Project, Bissau</gtr:description><gtr:id>541196F7-16CA-4039-9820-1B965809BE04</gtr:id><gtr:impact>19841588</gtr:impact><gtr:outcomeId>015932FE08D-2</gtr:outcomeId><gtr:partnerContribution>there is a continued managerial and intellectual collaboration between the Bandim Health Project and the MRC-exchange of intellectual ideas
-inspiration
-practical help with samples</gtr:partnerContribution><gtr:piContribution>frequent updates on our study and visits to the Bandim Health Project, collaborations on setting up anti-retroviral treatment program in Caio</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>inform the Caio community about results of the study</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>8BBE498A-D661-4029-9764-70FFAA310BE3</gtr:id><gtr:impact>we gave feedback about the outcomes of the study to the people in the village of whom a large proportion had participated in our study

greater awareness of HIV in the village</gtr:impact><gtr:outcomeId>CEA03A5FC76</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>interview</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>CEAFFCA9-DE37-4B28-8716-D87043C3DCB3</gtr:id><gtr:impact>I was interviewed by a freely distributed, Dutch newspaper about HIV-2 research in West Africa

exposure of MRC in the Dutch media, read by a large public</gtr:impact><gtr:outcomeId>375EE4CB549</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>accelerated roll-out of anti-retroviral treatment program in Caio</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>4953BFB8-0001-4C7B-B9D0-470EDA503AAA</gtr:id><gtr:impact>the results of the study and the commitment to HIV patients shown by the field station in Caio were used to accelerate and start an anti-retroviral treatment program in Caio, provided through the national AIDS program in Guinea-Bissau</gtr:impact><gtr:outcomeId>E0746CCBE62</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>EE6182A6-66CE-4F87-9605-1A0A39D4D72E</gtr:id><gtr:title>HTLV-1 and HIV-2 infection are associated with increased mortality in a rural West African community.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e3bb178c459f02e14fcf720afb9e75e8"><gtr:id>e3bb178c459f02e14fcf720afb9e75e8</gtr:id><gtr:otherNames>van Tienen C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_12576_26_22194980</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C8A90916-C930-470F-890A-647E34B399AB</gtr:id><gtr:title>Two distinct epidemics: the rise of HIV-1 and decline of HIV-2 infection between 1990 and 2007 in rural Guinea-Bissau.</gtr:title><gtr:parentPublicationTitle>Journal of acquired immune deficiency syndromes (1999)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/51e1b118377280b8855a5294b9785d5c"><gtr:id>51e1b118377280b8855a5294b9785d5c</gtr:id><gtr:otherNames>Tienen Cv</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1525-4135</gtr:issn><gtr:outcomeId>BB5543455B6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>29C9A414-E459-4145-809F-20A8C3AB8751</gtr:id><gtr:title>Molecular epidemiology of endemic human T-lymphotropic virus type 1 in a rural community in Guinea-Bissau.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e3bb178c459f02e14fcf720afb9e75e8"><gtr:id>e3bb178c459f02e14fcf720afb9e75e8</gtr:id><gtr:otherNames>van Tienen C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>DSYqUwbMz4k</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0E16B4B1-385A-4751-99BC-C8E3B91501A1</gtr:id><gtr:title>Clinical predictors cannot replace biological predictors in HIV-2 infection in a community setting in West Africa.</gtr:title><gtr:parentPublicationTitle>International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b24ec7623b969cce808560f0704b0bbf"><gtr:id>b24ec7623b969cce808560f0704b0bbf</gtr:id><gtr:otherNames>Gourlay AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1201-9712</gtr:issn><gtr:outcomeId>pm_12576_26_22387142</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1C60CEBD-8B01-417E-B4E5-8C6C73977553</gtr:id><gtr:title>HTLV-1 in rural Guinea-Bissau: prevalence, incidence and a continued association with HIV between 1990 and 2007.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e3bb178c459f02e14fcf720afb9e75e8"><gtr:id>e3bb178c459f02e14fcf720afb9e75e8</gtr:id><gtr:otherNames>van Tienen C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn><gtr:outcomeId>AHUWEz5hnm1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F188EEEE-F412-495B-B335-3E4F873A33C3</gtr:id><gtr:title>Maternal proviral load and vertical transmission of human T cell lymphotropic virus type 1 in Guinea-Bissau.</gtr:title><gtr:parentPublicationTitle>AIDS research and human retroviruses</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e3bb178c459f02e14fcf720afb9e75e8"><gtr:id>e3bb178c459f02e14fcf720afb9e75e8</gtr:id><gtr:otherNames>van Tienen C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0889-2229</gtr:issn><gtr:outcomeId>pm_12576_26_22066980</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U190081997</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>9A8BEDCC-D902-4C9A-8CCF-C974265EA3FB</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.4  Surveillance and distribution</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>